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M-type (Kv7, KCNQ) potassium channels are proteins that control excitability of neurons and muscle 
cells. Many physiological and pathological mechanisms of excitation operate via the suppression of M 
channel activity or expression. Conversely, pharmacological augmentation of M channel activity is a 
recognized strategy for treatment of hyperexcitability disorders such as pain and epilepsy. However, 
physiological mechanisms resulting in M channel potentiation are rare. Here we report that intracellular 
free zinc directly and reversibly augments activity of recombinant and native M channels. This effect is 
mechanistically distinct from the known redox-dependent KCNQ channel potentiation. Interestingly, 
the effect of zinc cannot be attributed to a single histidine- or cysteine-containing zinc binding site 
within KCNQ channels. Instead, zinc dramatically reduces KCNQ channel dependence on its 
obligatory physiological activator, phosphatidylinositol 4,5-bisphosphate (PIP2). We hypothesize that 
zinc facilitates interactions of the lipid-facing interface of a KCNQ protein with the inner leaflet of the 
plasma membrane in a way similar to that promoted by PIP2. Since zinc is increasingly recognized as a 
ubiquitous intracellular second messenger, this discovery might represent a hitherto unknown native 







M-type (Kv7, KCNQ) potassium channels are powerful regulators of neuronal and muscular 
excitability and are validated drug targets for treatment of excitability disorders. The plasma membrane 
phosphoinositide phosphatidylinositol 4,5-bisphosphate (PIP2) is required to maintain M channel 
activity. We report that intracellular free zinc directly and reversibly augments activity of recombinant 
and native M channels by reducing or virtually abolishing channel requirement for PIP2, thereby 
permitting a PIP2-gated ion channel to operate independently of this important signaling molecule. 
Given the growing recognition of zinc is as an intracellular second messenger, this phenomenon might 
represent a hitherto unknown pathway of M channel modulation and provide a fresh strategy for design 








M-type (KCNQ, Kv7) K+ channels are a family of voltage-gated K+ channels with a very 
distinctive and robust role in the control of cellular excitability. The channels give rise to non-
inactivating K+ currents with slow kinetics and a very negative activation threshold (-60 mV or even 
more negative). In combination, these features allow KCNQ channels to remain partially active at 
voltages near the resting membrane potential of a neuron or a muscle cell and, thus, strongly influence 
excitability (1, 2). Transient KCNQ channel inhibition leads to reversible increases in neuronal 
excitability while long-term losses of KCNQ channel activity often result in debilitating excitability 
disorders (1, 2). Thus, loss-of-function mutations within KCNQ genes underlie some types of epilepsy, 
deafness and arrhythmias, while transcriptional downregulation in sensory nerves may result in chronic 
pain (2). Conversely, M channel enhancers (‘openers’) reduce excitability and are clinically used as 
antiepileptic drugs (e.g. retigabine) or analgesics (e.g. flupirtine) (3). Therapeutic utility of KCNQ 
channel openers extends to other disorders linked to deregulated excitability, such as anxiety, stroke, 
smooth muscle disorders (2, 3); therefore a global quest for specific and selective KCNQ openers is 
currently underway (3).  
The KCNQ channel family contains 5 members (KCNQ1-5, Kv7.1-Kv7.5); KCNQ1 is mostly 
expressed within the cardiovascular system while other members are predominantly neuronal (1, 2). 
The most abundant M-type channel within the nervous system is believed to be the heteromeric 
KCNQ2/3 channel, although other homo-and heteromeric channels are also present (1, 2).  
In addition to voltage, KCNQ channels are also sensitive to the plasma membrane 
phosphoinositide, phosphatidylinositol 4,5-bisphoshpate (PIP2) (4, 5). Accordingly, G protein coupled 
receptor-mediated PIP2 depletion is one of the major mechanisms of excitatory action of endogenous 
neurotransmitters and neuromodulators such as acetylcholine, angiotensin II, glutamate and others 
(reviewed in (1, 2)). Excised patch single channel recordings of KCNQ2-4 and KCNQ2/3 channels 
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revealed that their open probability (Po) approaches zero when PIP2 is depleted, whereas increasing 
concentrations of exogenous PIP2 raise Po up to unity (6). It has also been determined that KCNQ3 has 
over 20 fold higher apparent PIP2 affinity as compared to KCNQ2 and KCNQ4 (6, 7). As a result, tonic 
membrane PIP2 levels in cells such as Chinese hamster ovary (CHO) are sufficient to maintain Po of 
KCNQ3 homomers at near unity (at saturating voltages), while homomeric KCNQ2 and KCNQ4 
channels display very low Po values of 0.1 - 0.2 (6, 8). The elucidation of the structural background of 
the KCNQ channel interaction with PIP2 is ongoing but several important regions have been identified, 
including two clusters of positively charged amino acid residues within the channel carboxy-terminus 
as well as additional clusters within the cytosolic S2-S3 and S4-S5 linkers (reviewed in (9)). All the 
regions identified thus far are cytosolic and are presumed to facilitate interactions with the negatively 
charged phosphate groups of PIP2, facing the cytosol at the inner plasma membrane leaflet. 
Phosphorylation (10) or methylation (11) of residues within the C-terminal PIP2 binding site were 
reported to modulate PIP2 affinity and, in turn, KCNQ channel activity. Thus, modulation of the KCNQ 
channel PIP2 sensitivity may represent a new therapeutic approach to the treatment of excitability 
disorders, such as epilepsy and pain. 
In the present study we report that intracellular zinc ions potently augment the activity of 
heterologous and native KCNQ channels by reducing channel requirements for PIP2. The effect of zinc 
is reversible and most likely direct, as it can be demonstrated in excised membrane patches. Since zinc 
is being increasingly recognized as an important intracellular second messenger, this effect could 
represent an alternative regulatory signaling pathway for control over cellular excitability. While 
intracellular concentrations of free zinc are low (<1 nM; (12)), zinc is accumulated at high levels in 
various stores, such as ER, mitochondria and synaptic vesicles. In the latter, the concentrations of free 
zinc could reach millimolar level (13). During synaptic transmission vesicular zinc is released and 
quantities of zinc translocate to the postsynaptic terminals through zinc permeable channels such as 
6 
 
AMPA receptors (14). Additionally, zinc can be released from cytosolic buffering proteins such as 
metallothioneins, e.g. in response to acidification (15). Thus, there is clear scope for intracellular zinc 
signaling in neurons, including, for instance, postsynaptic rises during periods of high activity, hypoxia, 
neurotrauma etc. Therefore, this acute and rapidly reversible mechanism for ‘tuning’ KCNQ channel 
PIP2 sensitivity by zinc might represent a neuronal feedback mechanism for controlling excitability 
during periods of hyperexcitability. Yet, since M channel potentiation requires micromolar levels of 
intracellular zinc, future research is needed to establish if native M channels are indeed subjected to 




Zinc ionophores are KCNQ channel openers. Recent reports (16, 17) identified zinc pyrithione 
(ZnPy; Fig. S1) as an ‘atypical’ KCNQ channel opener and suggested that the pyrithione moiety 
(complexed with zinc) augments KCNQ channel activity by binding to a site within the extracellular 
pore region (16). It is also well recognized that ZnPy is a zinc ionophore which can effectively deliver 
free zinc ions across the plasma membrane of living cells (18, 19). Thus, we tested whether the effect 
of ZnPy on KCNQ channel activity is attributable to the ionophore activity of the former. To this end 
we overexpressed human KCNQ4 channels in CHO cells and tested the effect of five structurally 
distinct zinc ionophores on KCNQ4 currents. The following ionophores were used: ZnPy (18) (10 M), 
pyrrolidinedithiocarbamate (20) (PDTC; 20 M), zinc diethyldithiocarbamate (21) (Zn-DEDTC; 30 
M), tetrabutylthiuram disulphide (22) (zinc ionophore I; 20 M), and 5,7-Diiodo-8-hydroxyquinoline 
(DIQ; 50 M) (23). ZnPy and Zn-DEDTC already contained zinc as part of the complex (Fig. S1); 
other ionophores were used in combination with 25 M ZnCl2 in the extracellular solution. KCNQ4 
has been chosen because among homomeric Kv7 channels it displays the most reproducible and robust 
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expression in CHO cells (24). Live confocal imaging of intracellular free zinc levels confirmed that all 
five ionophores produced robust elevations of intracellular zinc (Fig. 1A-F); in each case these 
elevations were completely reversed by the application of zinc chelator, N, N, N’, N’, tetrakis (2-
pyridylmethyl) etylenediaminepentaethylene (TPEN; 20 M). TPEN has much higher zinc affinity as 
compared to other ionophores such as ZnPy and DIQ (Kd = 10-15.6 vs. KD  10-5 - 10-8 M) (25, 26) and is 
capable of ‘stripping’ zinc off intracellular proteins (25) and zinc-sensitive fluorescent indicators (19). 
We then performed perforated patch voltage clamp recordings to test the effects of these five 
ionophores on KCNQ4 current amplitude. Strikingly, despite having different chemical structures, all 
five compounds augmented KCNQ4 amplitude by 2-3 fold (Fig. 1G-L). As with intracellular zinc 
levels, the effect of each ionophore on KCNQ4 current amplitude was reversed by TPEN. Notably, 
TPEN did not normally inhibit KCNQ4 current below the baseline but only reversed the ionophore-
induced augmentation (Fig. 1L), suggesting that i) the effect of TPEN is likely to be mediated by zinc 
chelation, rather than by a direct effect on the channel; ii) tonic cytosolic levels of free zinc in CHO 
cells are too low to affect channel activity. Similar to KCNQ4, heteromultimeric KCNQ2/3 channels 
formed by KCNQ2-KCNQ3 concatemers overexpressed in CHO cells were potently augmented by 
ZnPy, Zn-DEDTC and PDTC; these effects were completely reversed by TPEN (Fig. 2A, B). In accord 
with previous findings, ZnPy induced leftward shifts of the voltage-dependence of KCNQ4 and 
KCNQ2/3 from -20.2±1.8 mV to -39.8±1.7 mV (n=8; p<0.001) and from -23.2±1.1 mV to -28.6±2.0 
mV (n=6; p=0.089) respectively (Fig. S2).  
Interestingly, Na+ pyrithione (NaPy; 10 M) also induced KCNQ4 current augmentation. The 
effect was slower and smaller in amplitude as compared to that induced by ZnPy, but nevertheless 
significant (Fig. S3A, B). Thus, NaPy augmented KCNQ4 current by 1.6±0.1 fold (n=7; p<0.01) and 
subsequent transient application of ZnPy to the same cells caused further augmentation (2.1±0.3 fold 
relative to baseline), which was significantly higher than the NaPy effect (p<0.01; Fig. S3A, B). 
8 
 
Finally, application of TPEN (in the presence of NaPy) reverted current amplitude to values that were 
slightly (but not significantly) below the baseline. Surprisingly, zinc imaging revealed that extracellular 
application of NaPy produced a moderate but significant elevation of intracellular zinc (Fig. S3C). We 
measured if our NaPy reagent (purchased from Sigma) is contaminated by zinc using atomic absorption 
spectroscopy (19) but found that the contamination was negligible. Thus, 100 mM solution of NaPy 
contained 1.4 ± 0.5 M zinc (n=4) and in lower dilutions zinc was not reliably detectable. It is therefore 
likely that the effect was a result of zinc release from intracellular stores or, alternatively, it could be a 
result of a pyrithione-mediated zinc influx from the extracellular side, since extracellular solutions, 
while nominally zinc-free, do contain micromolar zinc traces (19). Regardless of the source though, it 
is clear that i) NaPy produces increases in the intracellular free zinc concentration; ii) augmentation of 
KCNQ4 current by NaPy is reversed by the zinc chelator, TPEN. Thus, we conclude that the action of 
intracellular zinc is responsible for KCNQ4 current augmentation by NaPy. 
Intracellular zinc can augment activity of unitary KCNQ channels. Experiments thus far 
established a correlation between the intracellular zinc levels and macroscopic KCNQ current 
amplitude. But is intracellular zinc alone sufficient to augment KCNQ channel activity? To answer this 
question we performed inside-out excised patch recordings of unitary KCNQ2/3 concatemeric channels 
overexpressed in CHO cells (as described in (6); see Methods). We measured single channel Po at a 
saturating voltage (0 mV). Patches with some single-channel activity in cell-attached mode were 
excised into inside-out configuration; upon excision channel activity declined sharply, displaying 
almost no activity (Fig. 2C-F), in accord with previous findings (6, 27). This sharp rundown of channel 
activity upon patch excision is likely due to the depletion of membrane PIP2 by the membrane-bound 
lipid phosphatases present in the patch membrane and is characteristic of virtually all PIP2 sensitive ion 
channels (28). Addition of increasing concentrations of ZnCl2 to the intracellular side of the patch 
produced concentration-dependent restoration of KCNQ2/3 channel activity such that their Po rose 
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from near zero to 0.26±0.09, 0.68±0.07 and 0.75±0.05 at 10, 50 and 100 M ZnCl2 respectively (Fig. 
2C-F; n=5; p<0.001). In our experiments single concatemeric KCNQ2/3 channel current amplitudes at 
0 mV were somewhat higher than these reported for channels formed by independently overexpressed 
KCNQ2 and KCNQ3 subunits (1.21±0.11 pA, n=7 vs. ~0.7 pA (6, 7)), although kinetics and voltage 
dependence of macroscopic currents were similar (e.g. Fig. S2D). The single-channel experiments 
demonstrated that intracellular zinc ions are sufficient to augment KCNQ channel activity and, thus, 
most likely to account for the KCNQ ‘opener’ action of zinc ionophores. Application of ZnCl2 (up to 
50 M) to the extracellular side of the plasma membrane in whole-cell experiments failed to augment 
KCNQ4 current but produced weak but rapid inhibitory effect instead (Fig. S4). 
Zinc potentiates native M channels in dorsal root ganglion neurons. We next tested if zinc 
can potentiate the activity of native M channels. M channels are expressed in mammalian 
somatosensory neurons (especially in ‘pain’ or nociceptive neurons) and are important for control of 
their resting excitability (29, 30), ultimately controlling nociceptive signalling (reviewed in (31)). Thus, 
we tested the effect of intracellular zinc on the M current in cultured small-diameter (presumed 
nociceptive) rat dorsal root ganglion (DRG) neurons. Similar to the currents produced by 
overexpressed KCNQ channels, native M current in DRG neurons was also augmented by ZnPy (10 
M) to 1.65±0.24 of basal amplitude (Fig. 3A, B; n=5; p<0.01). This effect was completely reversed by 
20 M TPEN, which, however, did not inhibit the current significantly below the basal level. Similarly 
to CHO cells, ZnPy also produced robust rises in intracellular zinc in cultured neurons (Fig. 3C, D), an 
effect that was again reversed by TPEN.  
To test if intracellular free zinc is sufficient for native M current augmentation we performed 
whole cell recordings with pipette solution supplemented with 50 M ZnCl2; in these recordings Ca2+, 
Mg2+ and Ca2+ buffers were excluded from the pipette solution. Upon breaking into the whole-cell 
configuration of patch clamp recording using the control pipette solution there was a small run-up of M 
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current amplitude (measured as ‘tail’ current relaxation upon voltage pulse from -30 to -60 mV, see 
Methods; Fig. 3E). This run-up was significantly potentiated when recording with ZnCl2-containing 
pipette solution. Accordingly, the plateau M current density was significantly larger in ZnCl2 solution 
as compared to control (4.8±0.3 pA/pF, n=14 vs. 8.9±1.0 pA/pF, n=14; p≤0.001; Fig. 3F). Thus, native 
M current in DRG neurons is also potently augmented by intracellular zinc. 
Modulation of KCNQ current by zinc is mechanistically distinct from the redox-dependent 
KCNQ current augmentation. Recently we and others reported augmentation of KCNQ channel 
activity via the oxidative modification of a triple-cysteine pocket in the channel S2-S3 linker (11, 24, 
32). Since zinc can bind to cysteines and form redox-sensitive molecular switches (33), we tested if the 
effect of zinc on KCNQ channels is also redox-dependent and mediated by the triple-cysteine pocket. 
We compared the effect of zinc with that of ascorbate, the latter having been shown to augment 
KCNQ4 channel activity in a redox-dependent way (32). In accord with previous findings, application 
of 2 mM ascorbate caused 2.5±0.9 fold increase of KCNQ4 current amplitude (n=6; p≤0.01; Fig. 4A, 
B, G); this effect was reversed by the reducing agent, dithiothreitol (DTT; 2 mM; Fig. 4A, G). In 
contrast, TPEN (20 M) did not reverse ascorbate-induced KCNQ4 current augmentation (Fig. 4B, G). 
Zinc imaging revealed that ascorbate does not produce a measurable increase of intracellular zinc (Fig. 
S5). On the other hand, the KCNQ4 potentiating effect of ZnPy (and other zinc ionophores) was 
reversed by TPEN (Fig. 1G-L; Fig. 4D, H) but not DTT (Fig. 4C, H). Most importantly, substitution of 
three cysteines within the redox-sensitive cysteine pocket by alanines C(156–158)A in KCNQ4 
resulted in a channel that was completely insensitive to ascorbate (Fig. 4E, I), yet C(156–158)A mutant 
channel currents were still sensitive to ZnPy (Fig. 4F, I; 3.1±0.7 fold potentiation, n=5; not different 
from the wtKCNQ4). These experiments suggest that augmentation of KCNQ currents by zinc is 




In search of the KCNQ zinc binding site. Zinc binding sites in proteins usually contain 
histidine or cysteine residues (with aspartic or glutamic acids also often participating in zinc 
coordination) (34). In order to identify a zinc binding site within the KCNQ channels we substituted 
with alanines all the individual intracellular histidines and also the intracellular cysteines conserved 
between KCNQ2-4 (Fig. 5A, inset); we used KCNQ4 as a backbone for these experiments. These 
substitutions included the following residues: histidines at the positions 102, 234, 330, 334, 569 and 
669 as well as cysteines at the positions 112, 156-158, 175, 418, 427 and 519. We also tested a KCNQ4 
channel with a histidine-less carboxy-terminus - H(330,334,569,669)A as well as a triple-cysteine 
substitution at positions C(156-158)A (see above). Surprisingly, none of these individual or group His 
or Cys substitutions abolished channel sensitivity to ZnPy (Fig. 5A). Only in the H569A mutant was 
the current augmentation somewhat lower (1.6±0.2 fold increase, n=7 vs 2.4±0.4 fold in wtKCNQ4, 
n=8), but this was not statistically significant. These experiments revealed that neither intracellular 
histidines nor cysteines (either individually or in clusters) can fully account for zinc-induced KCNQ 
current potentiation and thus some other mechanisms must be involved. 
Surprisingly, H334A displayed dramatically enhanced ZnPy-induced potentiation as compared to 
wtKCNQ4 (Fig. 5A, Fig. S6); the mutant also had much smaller basal current amplitude (Fig. S6B, D). 
A similar tendency (although less pronounced) was displayed by the quadruple-His mutant, which also 
has H334 replaced (Fig. 5A, Fig. S6C, D). Interestingly, H334 in KCNQ4 is equivalent to H328 in 
KCNQ2, a residue which was identified as one of the key determinants of channel interaction with PIP2 
(5). The reduced apparent affinity to PIP2 of H334A mutant correlates well with reduced baseline 
current amplitude. However, the strong enhancement of the baseline current by ZnPy to levels even 
higher than those produced by wtKCNQ4 may suggest that zinc reduces channel requirements for PIP2. 
Our single-channel experiments also hinted to the same hypothesis: KCNQ channels have a permissive 
requirement for PIP2 and when membrane PIP2 is depleted, as in the case of an inside-out excised patch 
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(28), single KCNQ channels activity runs down rapidly to almost zero (5, 6) (Fig. 2C-F). Yet, addition 
of zinc to the intracellular side of the plasma membrane was able to rescue the KCNQ channel activity 
without replenishment of PIP2. We therefore asked if zinc can indeed interfere with channel 
requirement for PIP2. 
Zinc reduces KCNQ channel PIP2-dependence. First, we tested the effect of intracellular zinc 
on KCNQ3, a channel that, in contrast to KCNQ2 and KCNQ4, has high PIP2 affinity (6), such that 
tonic PIP2 levels in CHO cells are sufficient to maintain tonic maximal Po of this channel near unity 
(6). Since the KCNQ3 channel expresses poorly as a homomer (35, 36), we used KCNQ3 with a pore 
domain mutation A315T (KCNQ3T), which strongly increases KCNQ3 current amplitude without 
changing apparent PIP2 affinity (7, 36, 37). Interestingly, neither ZnPy nor PDTC had any effect on the 
KCNQ3T current amplitude (Fig. 5B, E, D, G), suggesting that the effects of PIP2 and zinc on channel 
activity are non-additive, meaning that zinc would have little effect on a given KCNQ subunit under 
conditions when the level of PIP2 is saturating.  
We then disabled two known C-terminal PIP2 interacting sites in KCNQ3T by i) deleting a linker 
between helices A and B (positons 411-508) that harbors a cluster of basic residues (including K425, 
K432, and R434) (38) and ii) introducing mutations R364A and H367C that neutralized the PIP2 
interacting site at the junction between the S6 and C-terminal helix A (5, 39); we labelled this mutant 
‘KCNQ3T-PIP2-Cterm’. Charge-neutralizing mutations within either of these sites were shown to 
reduce channel PIP2 affinity (5, 38, 39). Accordingly, KCNQ3T-PIP2-Cterm current amplitude was 
reduced over 10 fold as compared to the KCNQ3T channel (103.25±28.34 pA, n=12 vs. 1170±370 pA, 
n=10, p≤0.001). Strikingly, both ZnPy and PDTC produced 5-7 fold augmentation of KCNQ3T-PIP2-
Cterm current amplitude (Fig. 5C, D, F, G). These data suggest that the increased PIP2 dependence of the 
KCNQ3T-PIP2-Cterm mutant can be compensated by intracellular zinc. 
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Next, we used a similar strategy to reduce PIP2 affinity of KCNQ4 to test how this would affect 
zinc effects on this channel. This time we targeted a different PIP2-interacting site, the S4-S5 linker. 
We neutralized one of the basic residues by introducing a K236L substitution (Fig. 5A, inset) at a 
position equivalent to K222 in KCNQ3, which was shown to be involved in the interaction with PIP2 
(17). As in the case with KCNQ3T-PIP2-Cterm, KCNQ4 K236L mutant had much reduced current 
amplitude as compared with the wtKCNQ4 (Fig S7, A-D). However, ZnPy produced much stronger 
current augmentation of the mutant: 16.1±4.4 fold (n=10) vs. 2.4±0.4 fold (n=7; p≤0.01; Fig. S7A, B, 
E). To probe further the relationships between the channel PIP2 requirement, PIP2 levels and 
potentiation by zinc, we increased tonic PIP2 levels in CHO cells by overexpressing the key enzyme of 
PIP2 synthesis, PI(4)5-kinase (which phosphorylates phosphatidylinositol 4-phosphate to PIP2); this 
maneuver has been shown to increase maximal Po and macroscopic current density of KCNQ2 and 
KCNQ2/3 in CHO cells (6). PI(4)5-kinase overexpression indeed significantly increased current 
amplitudes of both wtKCNQ4 and KCNQ4 K236L, and, as expected, had a stronger effect on the latter 
(Fig. S7C, D). In PI(4)5-kinase overexpressing CHO cells ZnPy still augmented current amplitudes of 
both wt and K236L mutant channels but, notably, the maximal current amplitudes in the presence of 
ZnPy were the same in CHO cells with and without PI(4)5-kinase overexpression (Fig. S7C, D). 
Accordingly, the degree of the ZnPy-induced augmentation of the KCNQ4 K236L current (relative to 
baseline) in the presence PI(4)5-kinase was strongly reduced (Fig. S7E) and was no longer different 
from the augmentation of wtKCNQ4 in the absence of PI(4)5-kinase. 
Collectively, experiments presented in Fig. 5B-G and Fig. S7, together with the single-channel 
data (Fig. 2C-F), suggest that i) at saturating PIP2 levels intracellular zinc can no longer increase 
channel activity; ii) the lower the level of channel saturation with PIP2, the higher is the augmenting 
effect of zinc; iii) even when PIP2 saturation is below the threshold for channel activation (e.g. in 
inside-out patches), KCNQ channels can still be activated by zinc. 
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Finally, we asked how presence of intracellular zinc affects KCNQ channel sensitivity to acute 
PIP2 depletion and recovery. We utilized the voltage sensitive phosphatase from Ciona intestinalis 
(ciVSP). This enzyme is activated by strong depolarization; when overexpressed it is capable to 
robustly deplete membrane PIP2 (40) and almost completely inhibit KCNQ channel activity (41, 42). 
We overexpressed ciVSP with either KCNQ4 or with KCNQ2/3 concatemer in CHO cells and recorded 
currents during the ciVSP activation. Cells were held at -80 mV and three-step pulses (Fig. 6A1) were 
applied: i) 1-s step to -20 mV (close to the threshold for ciVSP activation (40, 43) but near the half-
maximal voltage for KCNQ channel activation (2)); ii) 1-s step from -20 mV to 120 mV (close to the 
saturating voltage for ciVSP (40, 43)); iii) 30-s step from 110 mV to -20 mV. At the end of the protocol 
voltage was returned to the holding potential. In the control conditions during step i) KCNQ channels 
are activated; during step ii) KCNQ channel current is first increased due to the increased driving force 
but then begin to decline due to the ciVSP activation and PIP2 depletion. At the beginning of step iii) 
PIP2 is depleted and KCNQ channels are inhibited but because of the ciVSP deactivation and PIP2 re-
synthesis, at the end of this step KCNQ activity recovers (Fig. 6A1, B1, C1, D1; black traces). Since 
steps i) and iii) are recorded at the same voltage (-20 mV), the difference between current amplitudes at 
the end of step i) and the beginning of step iii) represents KCNQ current inhibition by the ciVSP-
induced PIP2 depletion, while the difference between amplitudes at the end of step i) and the end of 
step iii) represents current recovery due to PIP2 re-synthesis (41). In accord with previous findings, 
ciVSP activation induced 70-80% inhibition of both KCNQ2/3 (Fig. 6A, B) and KCNQ4 (Fig. 6C, D) 
and in both cases current completely recovered at the end of the step iii). Application of either ZnPy or 
PDTC completely abolished PIP2-dependent inhibition of both KCNQ channels (Fig. 6A1, B1, C1, D1; 
red traces). Application of TPEN after (and in the presence of) ZnPy, recovered the ability of ciVSP to 
inhibit KCNQ2/3 channel (Fig. 6A1, A2).  
15 
 
In order to test if zinc inhibits ciVSP itself, we used an optical method of measuring ciVSP 
activity in which we co-expressed the enzyme in CHO cells together with KCNQ4 and the optical PIP2 
reporter PLC-PH-GFP (44) and measured its translocation from membrane to cytosol in response to 
depolarization by extracellular solution containing 150 mM KCl instead of NaCl (45). Intracellular K+ 
concentration in CHO cells is ~140 mM (46), thus such maneuver depolarized membrane potential to 
~+2 mV, which is sufficient to trigger measurable ciVSP activation (43, 45). Accordingly, confocal 
imaging of the plasma membrane PIP2 labelled by PLC-PH-GFP revealed clear and reversible, 
depolarization-induced PIP2 depletion manifested in PLC-PH-GFP translocation and an increase in 
cytosolic fluorescence (and concomitant decrease in membrane fluorescence; Fig. 6E). This 
translocation was not affected by extracellular application of ZnPy, suggesting that zinc does not 
significantly affect ciVSP activity. 
Muscarinic inhibition of KCNQ channels is mediated by Gq/11-induced activation of 
phospholipase C (PLC) via depletion of PIP2 (4, 5). Additionally, inositol trisphosphate-dependent Ca2+ 
transients (mediated by calmodulin) and diacylglycerol-dependent protein kinase C (PKC) 
phosphorylation are also thought to contribute to muscarinic KCNQ channel inhibition. Both of these 
additional mechanisms are thought to work by decreasing channel PIP2 affinity (reviewed in (2)). Thus, 
if intracellular zinc reduces channel dependence on PIP2, it would be expected that in the presence of 
zinc muscarinic inhibition of KCNQ channels will be reduced or abolished. Indeed, in CHO cells 
overexpressing KCNQ4 and M1 muscarinic receptor pre-application of ZnPy reduced KCNQ current 






The major findings of this study are the following. i) Intracellular zinc strongly potentiates native 
and recombinant KCNQ channel activity. ii) Any zinc ionophore is a potential KCNQ channel opener. 
iii) Zinc reversibly reduces or perhaps even abolishes KCNQ channel requirement for PIP2. iv) 
Mechanistically, the zinc effect is distinct from the known redox-dependent KCNQ channel 
potentiation; also, the effect cannot be attributed to a histidine- or cysteine-containing binding site.  
Several lines of evidence indicate that zinc strongly reduces KCNQ channel requirement for PIP2. 
Thus, i) unitary KCNQ2/3 channel activity quickly runs down upon patch excision, due to PIP2 
depletion (5, 28); yet, addition of free zinc to the intracellular side of the membrane maximizes channel 
activity (Fig. 2C-F). ii) KCNQ3 is insensitive to zinc ionophores (Fig. 5B-G; (17)); this channel has 
highest apparent affinity for PIP2 in the KCNQ family and its tonic Po max at saturating voltages is 
close to unity, presumably due to saturation with PIP2 (6). Removal of C-terminal PIP2 interacting 
residues resulted in a channel with much lower tonic activity which can be ‘rescued’ by intracellular 
zinc (Fig. 5B-G). iii) Similarly, efficacy of ZnPy to augment KCNQ4 current is higher for the mutant 
with reduced PIP2 affinity. iv) Elevation of tonic PIP2 levels by overexpression of PI(4)5-kinase 
reduced KCNQ channel sensitivity to zinc. v) Finally, acute PIP2 depletion by ciVSP or M1 receptor 
activation sharply inhibits KCNQ2/3 and KCNQ4 currents but this inhibition is abolished by zinc (Fig. 
6A-D, Fig. S8). It appears that zinc can compensate for the channel’s desaturation with PIP2 due to 
either acute PIP2 depletion or reduction in PIP2 affinity. On the other hand, the more saturated a 
channel protein is with PIP2, the lower is zinc efficacy.  
How might zinc interact with KCNQ channels and so dramatically affect channel-PIP2 
interaction; is there a unique zinc binding site? It is worth noting that interaction between KCNQ 
channels and PIP2 cannot be pin-pointed to a unique, localized binding site. Instead, the channel 
appears to form a broad PIP2-interacting interface whereby basic residues, spread along all main 
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cytosolic domains of a channel, participate in electrostatic interactions with the negatively charged 
headgroup phosphates of PIP2. Thus, basic residues in the S2-S3 linker (47, 48), S4-S5 linker (17, 49), 
S6-proximal C-terminus linker (5, 39), C-terminal A-B helix linker (38) and distal C-terminus (49) 
were identified and charge neutralisation mutations within most of these sites resulted in reduced 
apparent PIP2 affinity and reduced tonic channel activity (reviewed in (9)). Another important point is 
that not only PIP2, but other phosphoinositides such as PIP, PI(3,4)P, PI(3,4,5)P (6, 27) and even other 
phospholipids such as lysophosphatidic acid and sphingosine-1-phosphate (27) can activate KCNQ 
channels. Under normal physiological circumstances these interactions are thought not to affect KCNQ 
channel activity significantly due to the low plasma membrane abundance of these other lipids (relative 
to that of PIP2) (2, 27). However, should the affinity of channel-lipid interaction increase, these minor 
phospholipids may move into play. One explanation for the activating effect of zinc could therefore be 
that it serves as electrostatic ‘glue’ that stabilizes interaction of the KCNQ channel’s phospholipid 
interface with inner leaflet of the plasma membrane (Fig. 7). Perhaps by interacting with the 
negatively-charged amino-acid residues within the channel-membrane interface zinc ions strengthen 
the interactions of the positively-charged amino-acids with negatively-charged headgroups of 
phospholipids. This may either reduce the channel’s selectivity towards phospholipids (such that other 
negatively charged lipids may become capable to substitute for PIP2 anchoring) or dramatically 
increase its apparent affinity for PIP2, or have a combination of the above effects resulting in stabilizing 
channel opening.  
Interestingly, magnesium has been shown to decrease KCNQ channel activity, presumably by 
shielding PIP2 and weakening KCNQ channel-PIP2 interaction (50). It is unclear why the effects of zinc 
and magnesium on KCNQ channel activity are so different, one consideration though is that as a 
transition metal, zinc has a much higher (as compared to magnesium) ability to form chelate complexes 
(see e.g. http://www.coldcure.com/html/stability_constants.html) and, potentially, to coordinate tertiary 
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protein structures. Thus, zinc could potentially be better suited to stabilize KCNQ channel-membrane 
interactions. Yet, future structural studies are required to comprehensively address this question. 
Another intriguing question is whether the ‘PIP2 rescue’ effect of zinc can affect other PIP2-
sensitive channels. We tested the effect of ZnPy on another PIP2-sesnitive channel, Kir2.3 (51) as well 
as on a PIP2-insensitive channel, Kv1.4 (42). However, both of these channels were inhibited by ZnPy 
to a various degree (Fig. S9). The likely explanation here is that zinc might act as a pore blocker or 
inhibitor of these channels; there could also be additional inhibitory mechanisms (e.g. induced by the 
ionophore). Thus, while zinc may indeed reduce PIP2 dependence of other PIP2-sensitive channels, 
only those reasonably insensitive to zinc as a blocker would exhibit augmentation of activity. KCNQ 
channels are indeed not very sensitive to such inhibition (Fig. S4). 
Our hypothesis (Fig. 7) can also explain highly variable efficacies of ZnPy observed in various 
studies. Thus, a dramatic 24-fold augmentation of KCNQ4 current (at saturating voltages) was reported 
(16), whereas the effect on KCNQ2/3 channels in that study was much smaller (~2-fold). In our hands 
the augmentation of KCNQ4, KCNQ2/3 and native M channels by ZnPy, other zinc ionophores and by 
intracellular zinc in whole-cell recordings was in the range of 1.5 – 3 fold (Fig. 1-3,  (52)). However, 
much stronger effects were observed when either PIP2 levels were depleted (Fig. 2C-F) or when PIP2 
affinity of the channels was reduced by mutagenesis (Fig. 5; Fig. S6). Thus, it is expected that the 
efficacy of ZnPy to augment KCNQ channel activity in any particular experimental setting will 
strongly depend on the channel saturation with PIP2. 
Our findings confirm the discovery of ZnPy as a potent KCNQ channel opener (16), however, 
our study differs significantly from the original publication in the interpretation of the mechanism of 
ZnPy action. It was originally proposed that the effect is produced by the pyrithione moiety (in 
complex with zinc) binding to the channel’s pore region from the extracellular side (16). Below we 
briefly discuss differences between the study (16) and our investigation. i) Xiong and colleagues 
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reported only marginal effects of other zinc ionophores, DEDTC, DIQ and -tocopherol on KCNQ2 
channels. Zinc ionophore activity of -tocopherol is not well documented, but the lack of effect of 
DEDTC and DIQ is perplexing as in our hands both ionophores (as well as three others) strongly 
augmented KCNQ currents (Fig. 1). We also show that all the ionophores tested produced strong 
intracellular zinc accumulation (Fig. 1); since no such measurements were performed in study (16), we 
suggest that under their experimental conditions ZnPy was superior to other ionophores in loading cells 
with zinc. ii) Dialysis of 10 M ZnPy through the recording pipette did not significantly affect KCNQ2 
current amplitude but extracellular ZnPy was still effective. It was therefore suggested that ZnPy acts 
from the extracellular side. However, this experiment is hard to interpret as it is not clear how much 
free intracellular zinc has been delivered in such a way. Our experiments demonstrated that direct 
application of ZnCl2 to the intracellular side of the excised patch (Fig. 2C-F) or by the dialysis through 
the whole cell pipette (Fig. 3F) strongly potentiated both recombinant and native KCNQ channels. iii) 
The effect of 20 M NaPy on KCNQ2 current was marginal; it was proposed that KCNQ2 interacts 
with pyrithione with low affinity, but the affinity is increased when pyrithione is in complex with zinc 
(16). In our experiments NaPy produced a significant increase of KCNQ4 current but, importantly, also 
elevated intracellular zinc, although both effects were much less pronounced as compared with ZnPy. 
This difference may arise from lower intracellular zinc store load of cells used in the previous study.  
Zinc is increasingly recognized as ubiquitous second messenger, perhaps comparable in this 
regard to calcium (53). Cytosolic free zinc levels at rest are too low to affect KCNQ channel activity 
(<1 nM; (12)); this is a likely explanation for the fact that while TPEN reversed KCNQ current 
augmentation by exogenous zinc, it rarely reduced the amplitude of KCNQ channels overexpressed in 
non-excitable CHO cells below the baseline. Yet, in the  synaptic vesicles of neurons zinc can reach 
millimolar levels (13); another releasable pool of zinc is bound to intracellular proteins such as 
metallothioneins (15). Vesicular zinc is released during synaptic transmission and loads postsynaptic 
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terminals through zinc permeable channels (e.g. AMPA (14)). Zinc can also be released from cytosolic 
buffers in response to acidification (15) observed in hypoxic conditions. In a recent study FluoZin3 
zinc imaging revealed large intracellular zinc transients (comparable to rises recorded in this study in 
response to zinc ionophores) in hippocampal pyramidal neurons in response to oxidative stress (14). It 
is therefore conceivable that augmentation of KCNQ channel activity by postsynaptic zinc 
accumulation could constitute a strategy to survive excitotoxicity produced by ischemia or other 
conditions linked to over-excitability, such as epileptic seizures. A strong protective role of M channels 
in ischemic brain injury and stroke has been demonstrated (8, 9). Importantly, since zinc makes KCNQ 
channels virtually insensitive to Gq/11 receptor inhibition, postsynaptic zinc elevations could maintain 
M channel activity in the face of enhanced neurotransmitter release. Further research is required to test 







Cell culture, transfection, mutagenesis. HEK 293 cells were cultured in DMEM and CHO cells 
in DMEM:F12 (1:1) media, both supplemented with GlutaMax I, 10% fetal calf serum, penicillin (50 
U/ml), and streptomycin (100 g/ml). DRG neurons from 7 days old Wistar were dissociated as 
previously described (29) and cultured in DMEM supplemented as above on glass coverslips that were 
coated with poly-d-lysine and laminin for 2–5 days in a humidified incubator (37oC, 5% CO2). CHO or 
HEK293 cells were transfected using Fugene® HD (Promega) with the following cDNA (routinely 
subcloned into pcDNA3.1): human KCNQ4 (accession number AF105202) and its mutants; KCNQ2/3 
concatemer (kind gift from Snezana Maljevic, Tubingen University, Germany); KCNQ3 A315T and its 
mutants (kindly provided by Mark Shapiro, University of Texas Health Science Center at San Antonio, 
Texas, USA); Type 1a PI(4)5-kinase (54); PLC-PH-GFP (55); ciVSP (40) (kind gift from Tibor 
Rohacs, Rutgers University, New Jersey, USA). The point mutations and truncations were introduced 
by site-directed mutagenesis using standard techniques and verified by sequencing. 
Whole-cell and perforated patch recordings. All recordings were made using an EPC10 
amplifier in combination with PatchMaster v2 software and analyzed using the FitMaster v2 (all from 
HEKA Instruments). Most of the whole-cell recordings were made using perforated patch clamp 
technique. The standard bath solution contained the following (in mM): 160 NaCl, 2.5 KCl, 1 MgCl2, 2 
CaCl2, 10 HEPES, pH 7.4 (with NaOH), 305–310 mosm/kg. The standard pipette solution contained 
the following (in mM): 160 KCl, 5.0 MgCl2, 5.0 HEPES, 0.1 BAPTA, 3 K2ATP, NaGTP, pH7.4 (with 
KOH), supplemented with amphotericin B (200-400 g/ml). The access resistance was typically within 
5 M. When recording from DRG neurons, small-diameter cells (~20 m) were selected. When 
applying ZnCl2 (50 M) to DRG neuron’s cytosol via patch pipette dialysis the conventional whole-
cell configuration was used. The pipette solution contained the following (in mM): 120 K-acetate, 35 
KCl, 5 NaCl, 3NaATP, 0.1 GTP, 10 HEPES, pH 7.3 with KOH. KCNQ/M currents were measured by 
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1-s square voltage pulse to -60 mv from a holding potential of 0 mV (CHO cells) or -30 mV (DRG 
neurons) applied every 2-s. Recombinant KCNQ current amplitude was defined as XE991-sensitive 
steady-state outward current amplitude at 0 mV. Native M current amplitude was defined as XE991-
sensitive ‘tail’ current amplitude upon voltage step from -30 to -60 mV. In experiments with ciVSP, 
cells were held at -80 mV and 3-step voltage pulses (1-s steps to -20 mV followed by 1-s step to 120 
mV and a 30-s step back to -20 mV) were applied with 3-s intervals. 
Single-channel recording. The inside-out KCNQ current recording and analysis were performed 
as before (6, 8). Channel activity was recorded 48–72 h after transfection; pipettes had resistances of 7–
15 M when filled with a solution of the following composition (in mM): 150 NaCl, 5 KCl, 1 MgCl2, 
and 10 HEPES, pH 7.4 (with NaOH). Extracellular solution contained the following (in mM): 175 KCl, 
4 MgCl2, and 10 HEPES, pH 7.4 (with KOH). The resting membrane voltage was assumed to be 0 mV. 
Currents were recorded using an EPC 10 amplifier (HEKA Instruments), sampled at 5 kHz, and filtered 
at 0.5–1 kHz. Single-channel data (including Po histogram generation) were analyzed using FitMaster 
software (HEKA Instruments). Methods for event analysis, Po and single-channel amplitude calculation 
were as in (6).  
Fluorescence imaging. Intracellular zinc imaging was performed as in (19). CHO cells or DRG 
cultures were loaded with FluoZin-3AM (5 M for 30 min at 37oC in the presence of 0.02% pluronic 
F-127). Cells were washed with extracellular bath solution composed of the following (in mM): 160 
NaCl; 2.5 KCl; 2 CaCl2; 1 MgCl2; and 10 HEPES; pH 7.4 (with NaOH). Cells were imaged using a 
Leica SP5 fluorescence imaging system assembled on a Leica DMI6000 microscope and illuminated 
with 488 nm light for 1200 ms (400 Hz) with a 2 s interval. In confocal PIP2 imaging experiments 
HEK293 cells transfected with PLC-PH-GFP and KCNQ4 were illuminated using Nikon A1 confocal 
microscope with a 488 nm argon laser. Images were collected on an electron multiplying CCD camera 
(DQC-FS; Nikon) using NIS Elements 4.0 imaging software (Nikon), which was also used for analysis.  
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Statistics. All data are given as mean±S.E.M. Differences between groups were assessed by 
Student’s t test (paired or unpaired, as appropriate) or one-way ANOVA with Bonferroni correction. 
The differences were considered significant at p ≤ 0.05.  
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Figure 1. Zinc ionophores potentiate KCNQ4. (A-E), Fluorescence imaging of CHO cells 
loaded with zinc fluorophore, FluoZin-3AM. Example time course of changes in FluoZin-3 
fluorescence during application of (A) zinc pyrithione (ZnPy;10 M), (B) pyrrolidinedithiocarbamate 
(PDTC; 20 M), (C) zinc diethyldithiocarbamate (Zn-DEDTC; 30 M), (D) tetrabutylthiuram disulfide 
(zinc ionophore I; 20 M), (E) 5,7-Diiodo-8-hydroxyquinoline (DIQ; 50 M). PDTC, DIQ and zinc 
ionophore I were supplemented 25 M ZnCl2. At the end of each recording zinc chelator, N, N, N’, N’, 
tetrakis (2-pyridylmethyl) etylenediaminepentaethylene (TPEN; 20 M) was added (still in the 
presence of appropriate ionophore). In these and all other time-course plots, periods of drug 
applications are indicated with the grey shading. (F) Summary of the experiments presented in (A-E); 
number of cells is indicated within the bars; asterisks indicate significant difference from the basal 
fluorescence with ***p<0.001 (paired t-test). (G-K) Perforated patch clamp recordings from the 
KCNQ4-transfected CHO cells showing the time courses for effects of zinc ionophores and TPEN (as 
labelled; applied as in panels A-E) on the KCNQ4 current amplitude. At the end of each recording a 
specific KCNQ channel inhibitor, XE991 (10 M), was applied. Example current traces are shown on 
the right; voltage protocol is given in the top inset in (G). (L) Summary of the experiments presented in 
(G-K); number of cells is indicated within the bars; asterisks indicate significant difference from the 
basal fluorescence with **p<0.01 (paired t-test). 
Figure 2. Effect of intracellular zinc on KCNQ2/3 channels. (A) Perforated patch clamp 
recordings from the CHO cells transfected with the KCNQ2/3 concatemer showing the effects of 
DEDTC (30 M), TPEN (20 M) and XE991 (10 M) (as labelled) on the M current amplitude. 
Example current traces are shown on the right. (B) Summary of the effects of ZnPy, PDTC and 
DEDTC on KCNQ2/3 currents; recordings were made as in Fig. 1G-K and Fig. 2 (A). Number of cells 
is indicated within the bars; asterisks indicate significant difference from the baseline with **p<0.01 
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(paired t-test). (C) Current records from a patch of CHO cell membrane containing a single KCNQ2/3 
channel in cell-attached mode with various concentrations of ZnCl2 in the ‘cytosolic’ bath solution. 
(D), Each 10 s sweep during the experiment was analyzed for channel open probability (Po), and the 
time course of the Po during the experiment is plotted. (E) All-point amplitude histograms for the 
sweeps shown on the panel (C). (F) Summary of the effect of intracellular ZnCl2 (10-100 M) on the 
KCNQ2/3 channel open probability (Po). Number of recordings is indicated within the bars; asterisks 
indicate significant difference from the control with **p<0.01 (paired t-test). 
Figure 3. Effect of intracellular zinc on the endogenous M current in dorsal root ganglion 
(DRG) neurons. (A) Time course of the effect of ZnPy (10 M), TPEN (20 M) and XE991 (3 M) 
on the M-like K+ current recorded from the small-diameter cultured rat DRG neuron. Example current 
traces are shown on the right; voltage protocol is depicted below the traces; summary is given in (B). 
(C) Fluorescence imaging of DRG cultures loaded with zinc fluorophore, FluoZin-3AM. Shown is 
the example time course of changes in FluoZin-3 fluorescence during application of ZnPy (10 M) and 
TPEN (20 M). Example fluorescence micrographs are shown in the inset on the right; summary is 
given in (D). Number of recordings is indicated within the bars; asterisks indicate significant difference 
from the baseline with *p<0.05 or **p<0.01 (paired t-test). (E) Example time courses of changes in M-
like current amplitude in DRG neurons upon breaking into whole-cell configuration with pipette 
solution containing no added zinc, Ca2+ or divalent cation buffers (Control) or the same solution 
supplemented with 50 M ZnCl2; summary is given in (E). In bar charts number of recordings is 
indicated within the bars. Asterisks indicate significant difference from the control with *p<0.05, 
**p<0.01 or ***p<0.001 (paired or unpaired t-test). 
Figure 4. Mechanism of KCNQ channel potentiation by zinc is distinct form the redox-
dependent modulation. (A, B) Perforated patch clamp recordings from the KCNQ4-transfected CHO 
cells; KCNQ4 current augmentation by ascorbate (Asc., 2 mM) was reversed by the reducing agent 
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dithiothreitol (DTT, 2 mM) (A) but not by 20 M TPEN (B). Example current traces are shown in the 
insets. (C, D) Experiments and analysis similar to these shown in (A-C) but ZnPy (10 M) was applied 
instead of ascorbate. In this case the KCNQ4 augmentation was reversed by TPEN but not DTT. (E, F) 
Effect of ascorbate (E) but not ZnPy (F) is abolished in KCNQ4 channel with C-to-A substitutions at 
the positions 156, 157 and 158. (G), (H) and (I) summarize the ascorbate (G) and ZnPy (H) 
experiments on wtKCNQ4 and the experiments on the KCNQ4 C(156-158)A. Number of recordings is 
indicated within the bars. Asterisks in (G), (H) denote significant difference from the group indicated 
by the line connector with *p<0.05 or **p<0.01 (paired t-test). Symbols in (I) indicate significant 
difference from either control (**p<0.001; paired t-test) or from current amplitude in the presence of 
ZnPy (#p<0.05; paired t-test). 
Figure 5. Intracellular zinc affects KCNQ channel interaction with PIP2. (A) Summary of 
the ZnPy-induced current augmentation (normalized to baseline) for single C-to-A and H-to-A KCNQ4 
mutants as well as for the C(156-158)A triple mutant and H(330,334,569,669)A quadruple mutant 
expressed in CHO cells. Schematic depiction of substitutions is shown in the inset. Asterisks indicate 
significant difference from wtKCNQ4 (***p<0.001; one-way ANOVA with Bonferroni correction). 
(B-G) Comparison of the effects of 10 M ZnPy (c-e) and 20 M PDTC (f-h) on the amplitude of the 
KCNQ3 A315T (KCNQ3T; B, E) or KCNQ3T with the C-terminal PIP2-interacting sites neutralized: 
deletion of A-B linker (positons 411-508) and R364A and H367C substitutions (KCNQ3T-PIP2-Cterm; 
C, F). (D) and (G) summarize the effects. Number of experiments is indicated within the bars. 
Asterisks indicate significant difference from control (**p<0.001; paired t-test). 
Figure 6. Intracellular zinc abolishes KCNQ channel inhibition by the voltage-sensitive 
phosphatase ciVSP. (A-B) Effects of 10 M ZnPy (A) and 20 M PDTC (B) on the ciVSP-induced 
inhibition of KCNQ2/3 concatemers in CHO cells. Example current traces are shown in (A1) and (B1); 
voltage protocol is given in the inset above traces in (A1). (A2) shows a time course of the effects of 
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ZnPy and recovery by TPEN on the ciVSP-induced inhibition of KCNQ2/3 (same experiment as that 
shown in A1). (A3) and (B2) summarize the effect of zinc ionophores on the ciVSP-induced KCNQ2/3 
current inhibition. (A4) and (B3) summarize the recovery from the ciVSP-induced inhibition in either 
the control conditions or in the presence of the ionophore (as indicated). Number of experiments is 
indicated within the bars. Asterisks and number symbols indicate significant difference from control 
and ZnPy, respectively (p<0.001; paired t-test). (C-D) are similar to (A-B) but KCNQ4 was tested. (E) 
Shows confocal imaging of the effect of ciVSP activation by depolarization (150 mM extracellular 
KCl; with or without 10 M ZnPy, as indicated) on the membrane localization of the optical PIP2 
reporter PLC-PH-GFP. Example time course is shown in (E1), images taken at the times indicated by 
the letters in (E1) are shown in (E2); corresponding intensity line-scans (at a position indicated by 
dotted red line in E2a) are shown below the images. Summary of the changes in cytosolic fluorescence 
intensity is shown in (E3); number of experiments is indicated within the bars. Asterisks indicate 
significant difference from control (p<0.001; repeated measures ANOVA). 
Figure 7. Hypothesis for the KCNQ channel stabilization by the PIP2 and intracellular zinc. 
Panel (A) shows an active channel in the presence of saturating PIP2 concentration; (B) shows a 
channel inhibited by PIP2 depletion (e.g. due to PLC or ciVSP activation). Sown in (C) is a channel in 
the absence of membrane PIP2 but stabilized by zinc, e.g. via ‘shielding’ the negatively-charged 
residues and coordinating the channel-membrane interface to strengthen the interactions with other 
phospholipids. Shown in (D) is a scenario of a sub-saturating membrane PIP2 level when the channel 
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Supplemental Figure legends. 
Figure S1. Chemical structure of zinc ionophores used. 
Figure S2. Effect of zinc pyrithione (ZnPy; 10 M) on the voltage dependence of KCNQ4 (A, B) 
and KCNQ2/3 (C, D) channels expressed in CHO cells. Voltage protocol is depicted in the inset in 
(B). Tail current amplitudes measured within first 5 ms of the final voltage step to -60 mV were 
plotted against main step voltage and fitted with Boltzmann function (A, C). Example current traces 
are shown in (B, D). 
Figure S3. Sodium pyrithione augments KCNQ4 current by raising intracellular zinc. (A) 
Perforated patch clamp recordings from the KCNQ4-transfected CHO cells showing the time 
courses for effects of 10 M sodium pyrithione (NaPy), 10 M ZnPy and 20 M TPEN (as 
labelled) on the KCNQ4 current amplitude. Example current traces are shown on the right; voltage 
protocol is given in inset above the traces. (B) Summary of the experiments presented in (A); 
number of cells is indicated within the bars; asterisks indicate significant difference from the 
baseline with **p<0.01 (paired t-test). (C) Fluorescence imaging of CHO cells loaded with zinc 
fluorophore, FluoZinTM-3AM. Mean time course of changes in FluoZin-3 fluorescence during 
application of 10 M NaPy followed by 10 M ZnPy; n=31.   
Figure S4. Extracellularly applied zinc does not augment KCNQ4 current. (A) Perforated 
patch clamp recording from the KCNQ4-transfected CHO cells showing the time courses for effects 
of 50 M ZnCl2 and 10 M XE991 (as labelled) on the KCNQ4 current amplitude. Example current 
traces are shown in the inset; voltage protocol is given in the inset above the traces. (B) Summary of 
the experiments as these presented in (A); number of cells is indicated within the bars. 
Figure S5. Ascorbate does not produce measurable increase of intracellular zinc levels. 
Fluorescence imaging of CHO cells loaded with zinc fluorophore, FluoZinTM-3AM. Shown are the 
example time courses of changes in FluoZin-3 fluorescence during application of 2 mM ascorbate 
and 10 M ZnPy (as labelled). Example fluorescence micrographs taken at the times indicated by 
the letters are shown in the inset. 
Figure S6. Replacement of C-terminal histidines in KCNQ4 increases the current potentiation 
efficacy of zinc. Perforated patch clamp recordings from the CHO cells transfected with the 
wtKCNQ4 (A), KCNQ4 H334A (B) or KCNQ4 H(330,334,569,669)A (C) showing the effects of 
10 M ZnPy and 10 M XE991 (as labelled) on the current amplitude. Example current traces are 
shown in the insets. Summaries of baseline current amplitudes and maximal ZnPy-induced current 
amplitudes (both measured at 0 mV) for the wtKCNQ4 and two mutants are shown in (D) and (E), 
respectively. Number of cells is indicated within the bars; asterisks indicate significant difference 
from the wtKCNQ4 with *p<0.05 or **p<0.01 (one-way ANOVA with Bonferroni correction). 
Figure S7. Neutralization of a PIP2-interacting residue in the S4-S5 linker of KCNQ4 
increases channel PIP2 dependence and current potentiation efficacy of zinc. Perforated patch 
clamp recordings from the CHO cells transfected with the wtKCNQ4 (A) or KCNQ4 K236L (B) 
showing the effects of 10 M ZnPy and 10 M XE991 (as labelled) on the current amplitude. 
Example current traces are shown in the insets. Panels (C, D) show summaries of baseline current 
amplitudes and maximal ZnPy-induced current amplitudes (both measured at 0 mV) for the 
wtKCNQ4 (C) or KCNQ4 K236L (D) overexpressed either alone or together with the PI(4)5-kinase 
(PI5K). Panel (E) summarizes the augmenting effect of ZnPy (normalized to baseline) for 
wtKCNQ4 or KCNQ4 K236L in CHO cells with or without PI(4)5-kinase co-expression (as 
labelled). Asterisks denote significant difference from the group indicated by the line connector 
with *p<0.05 or **p<0.01 (one-way ANOVA with Bonferroni correction). 
Figure S8. ZnPy reduces inhibition of Kv7.4 by M1 muscarinic receptor activation. (A) 
Perforated patch clamp recording from the KCNQ4-transfected CHO cells showing the time courses 
for effects of 20 M Oxotremorine-M (Oxo-M) and 10 M XE991 (as labelled) on the KCNQ4 
current amplitude. (B) Is similar to (A) but 10 M ZnPy was applied before Oxo-M. (C) Summary 
of the experiments as these presented in (A, B); number of cells is indicated within the bars. 
Asterisks and number symbols denote significant difference from the group indicated by the line 
connector with p<0.05, p<0.001 (paired or unpaired t-test, as appropriate). 
Figure S9. Effects of ZnPy on Kir2.3 and Kv1.4. (A-C) Effect of ZnPy on Kir2.3; (A) Whole-cell 
patch clamp recording from the HEK293 cells transfected with Kir2.3 (kind gift from Diomedis 
Logothetis, Virginia Commonwealth University School of Medicine) and GFP showing the time 
courses of the effect of 30 M of Kir channel inhibitor, ML133 on the Kir2.3 current amplitude. 
Currents were recorded by 250 ms voltage ramps from -160 to +20 mV from a holding potential of 
0 mV in response to application of ‘high-K+ solution’ of the following composition (in mM): NaCl 
5, KCl 140, CaCl2 2, MgCl2 1, HEPES 20 and Glucose 10, (pH 7.4 with NaOH). Control bath 
solution contained (in mM): NaCl 160, KCl 2.5, CaCl2 2, MgCl2 1, HEPES 10, and Glucose 8, (pH 
7.4 with NaOH). The intracellular solution contained (in mM): KCl 175, MgCl2 5, HEPES 5, 
BAPTA 0.1, K2ATP 3 and NaGTP 0.1 (pH 7.2 with KOH). (B) Example traces showing effects of 
ZnPy (1-10 M) on Kir2.3 currents recorded as in (A). (C) Summary of the experiments as 
presented in (B); maximal inward current amplitude at -160 mV is analysed. Number of cells is 
indicated within the bars. Asterisks denote significant difference from the control with p<0.05, 
p<0.001 (Repeated measures ANOVA). (D, E) Effect of ZnPy on Kv1.4; (D) Exemplary current 
traces recorded using whole-cell patch clamp from the HEK293 cells transfected with Kv1.4 
(Youbio, China) and GFP in control conditions and in the presence of 10 M ZnPy; voltage 
protocol is depicted below the traces. Recording solutions were as follows. The external solution 
contained (in mM): NaCl 140, KCl 5.4, CaCl2 2, MgCl2 1.0, HEPES 10 and glucose 10 (pH 7.3 
with NaOH); intracellular solution contained (in mM): KCl 140, Mg-ATP 4, MgCl2 1, CaCl2 1 and  
HEPES 10  (pH 7.4 with KOH). (E) Summary of the experiments as in (D); number of cells is 
indicated within the bars. Asterisks denote significant difference from the control with p<0.001 
(paired t-test). 
